Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5792 posts found.

Is the pharmaceutical sector prepared to face a titanium dioxide ban?

May 19, 2023 Manufacturing and Production ACG, EMA, EU, Titanium Dioxide

Dr Subhashis Chakraborty, head of Global Product Management, ACG Capsules In the wake of the ban on titanium dioxide (TiO2) …
News
Press release
glsun-mall-9xmv81sz5fw-unsplash

Boehringer Ingelheim invests €350m in Europe’s largest biotech development centre

April 28, 2023 Manufacturing and Production

Boehringer Ingelheim (BI) have announced that it will invest €350m in a state-of-the-art Biologicals Development Centre (BDC) in Germany. It …
News

Trade union Unite calls for GSK staff walkouts over pay increase disputes

April 20, 2023 Manufacturing and Production

UK-based trade union Unite is pushing for staff walkouts at several GSK manufacturing sites due to disputes regarding pay increases. …
News
pawel-czerwinski-2y8ol_obs1i-unsplash_2

FDA declines Eli Lilly’s bowel disease drug over manufacturing issues

April 14, 2023 Manufacturing and Production

Pharma giant Eli Lilly’s Biologic Licence Application (BLA) for its bowel disease drug has been declined by the FDA over …
News

UK and Polish regulatory authorities approve Akari Therapeutics’ higher-yielding manufacturing process

March 30, 2023 Manufacturing and Production

Akari Therapeutics has announced that the UK’s MHRA and the Polish Office for Registration of Medicinal Products, Medical Devices and …
News

Eli Lilly invests $1bn in Limerick manufacturing facilities

March 28, 2023 Manufacturing and Production

Pharma company Eli Lilly is increasing its investment in its new manufacturing facilities in Limerick, Republic of Ireland. Today’s announcement …
News

Moderna chooses Oxfordshire for new UK facility

March 6, 2023 Manufacturing and Production

US biotech firm Moderna has chosen Harwell Science Campus in Oxfordshire for its new UK R&D facility. The campus is …
News

REGENXBIO presents interim phase 2 data from drug developed on NAVXpress™ platform

February 13, 2023 Manufacturing and Production

REGENXBIO, a clinical-stage biotech company, has announced positive phase 2 data for their drug RXG-314, which was developed by the …
News

US Department of Justice asks Third Circuit to reinstate conspiracy charges again KVK

February 8, 2023 Manufacturing and Production

The US Department of Justice (DoJ) encouraged the Third Circuit to reinstate ‘conspiracy to defraud’ charges against Philadelphia-based generic drug …
News

Daiichi Sankyo to build Japan’s first factory for mRNA COVID-19 vaccines

February 6, 2023 Manufacturing and Production

Daiichi Sankyo have announced its plans to build Japan’s first factory for mRNA COVID-19 vaccines. The new facility is expected …
News

Eli Lilly plans to invest $450m at production site in Research Triangle Park

January 25, 2023 Manufacturing and Production

US-based pharmaceutical company, Eli Lilly and Company, has announced plans to invest $450m in its manufacturing facilities at Research Triangle …
News

Intas Pharmaceuticals under FDA scrutiny after oversight in GMP documents

January 20, 2023 Manufacturing and Production

India-based manufacturer Intas Pharmaceuticals has been issued a Form 483 by the FDA after three investigators found a “cascade of …
News

Johnson & Johnson scale back COVID-19 vaccination production

January 17, 2023 Manufacturing and Production

US-based Johnson & Johnson (J&J) have begun scaling back production of their COVID-19 vaccine due to demand falling over the …
News

$22m raised by PBS Biotech to expand single-use manufacturing products and services for cell therapy clients

January 9, 2023 Manufacturing and Production

PBS Biotech, an innovative, single-use bioreactor manufacturer and process development services provider, has worked together with Avego Management and BroadOak …
News

Sarepta Therapeutics and Catalent sign manufacturing deal for DMD gene therapy approval

January 9, 2023 Manufacturing and Production

Sarepta Therapeutics is a company focused on gene therapy, RNA and gene editing, engineering precision genetic medication for rare diseases. …
News
News alerts and subscriptions

Latest content

FDA approves first oral antiviral to treat adult patients with COVID-19

May 26, 2023

Scientists use AI to find new antibiotic to fight superbug

May 26, 2023

ZOLL remedē System receives FDA approval for sleep apnoea treatment

May 25, 2023
volodymyr-hryshchenko-m1hq4ibp9rc-unsplash

BioInvent and Transgene announce positive phase 1a solid tumour trial data

May 25, 2023

ElevateBio announced $401m in Series D financing for cell and gene therapies

May 25, 2023